Skip to main content Accessibility help
×
Home

Comparative Cost of Selective Screening To Prevent Transmission of Methicillin-Resistant Staphylococcus aureus (MRSA), Compared With the Attributable Costs of MRSA Infection

  • Laura Gavaldà (a1) (a2), Cristina Masuet (a1) (a2), Juan Beltran (a1) (a2), Maria Garcia (a1), Delia Garcia (a1), Josep M. Sirvent (a1) and Josep M. Ramon (a1) (a2)...

Abstract

The annual cost of a screening program to detect methicillin-resistant Staphylococcus aureus (MRSA) in a teaching hospital in Spain was €10,261. The average cost per MRSA infection was €2,730; therefore, the cost of the program would be covered if it only prevented 4 infections per year (11% of the total number of MRSA infections at our hospital).

Copyright

Corresponding author

Department of Preventive Medicine, Hospital Universitari de Bellvitge, Feixa Llarga, s/n. 08907 L'Hospitalet de Llobregat, Barcelona, Spain (lgavalda@csub.scs.es)

References

Hide All
1.Muto, CA, Jerigan, JA, Ostrowsky, BE, et al. SHEA guidelines for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003; 24:362386.
2. Report of a combined working party of the British Society for Antimicrobial Chemotherapy, the Hospital Infection Society and the Infection Control Nurses Association: revised methicillin-resistant Staphylococcus aureus infection control guidelines for hospitals. 1999. Available at: http://www.his.org.uk/. Accessed May 2004.
3.Garner, JS and the Hospital Infection Control Practices Advisory Committee. Guideline for isolation precautions in hospitals. Infect Control Hosp Epidemiol 1996; 17:5380.
4.Wakefield, DS, Pfaller, MA, Hammons, GT, Massanari, RM. Use of the Appropriateness Evaluation Protocol for estimating the incremental costs associated with nosocomial infections. Med Care 1987; 25:481488.
5.Zoutman, D, McDonald, S, Vethanayagan, D. Total and attributable costs of surgical-wound infections at a Canadian tertiary-care centre. Infect Control Hosp Epidemiol 1998; 19:254259.
6.Vilella, A, Prat, A, Trilla, A, Bayas, JM, Asenjo, MA, Salleras, L. Excess length of stay attributable to nosocomial bacteraemia: usefulness of the Hospitalization Appropriateness Protocol. Med Clin (Bare) 1999; 113:608610.
7.Kim, T, Oh, PI, Simor, AW. The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals. Infect Control Hosp Epidemiol 2001; 22:99104.
8.Karchmer, TB, Durbin, LJ, Simonton, BM, Farr, BM. Cost-effectiveness of active surveillance cultures and contact/droplet precautions for control of methicillin-resistant Staphylococcus aureus. J Hosp Infect 2002; 51:126132.
9.Lucet, JC, Chevret, S, Durand-Zaleski, I, Chastang, C, Reginer, B. Prevalence and risk factors for carriage of methicillin-resistant Staphylococcus aureus at admission on the intensive care unit. Arch Intern Med 2003; 163:181188.

Comparative Cost of Selective Screening To Prevent Transmission of Methicillin-Resistant Staphylococcus aureus (MRSA), Compared With the Attributable Costs of MRSA Infection

  • Laura Gavaldà (a1) (a2), Cristina Masuet (a1) (a2), Juan Beltran (a1) (a2), Maria Garcia (a1), Delia Garcia (a1), Josep M. Sirvent (a1) and Josep M. Ramon (a1) (a2)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed